N2TP Technology Solutions
Của N2TP Technology SolutionsN2TP builds an autonomous, formally verified AI platform for scientific discovery. Our hierarchical agentic runs a closed loop from Ideation → Method → Execution → Evidence, producing auditable, reproducible results with mathematical guarantees. The platform integrates formal verification, post‑training RL, and safety governance to make AI decisions trustworthy for safety‑critical domains such as biotech, healthcare, manufacturing, and supply chain.
- Giai đoạn
- Đang thí điểm
- Ngành
- Logistics
- Y tế
- Sản xuất
- Triển khai
- Kết hợp
Giá trị mang lại
- Formal‑first AI System with mathematical guarantees and auditable artifacts. - Plug‑and‑play safety layers that make existing LLM/agent systems deployment‑ready for regulated scientific workflows-delivering higher accuracy at lower cost, with reproducibility by design and accelerated time to evidence.
The scientific community faces a crisis. Seven out of ten experiments cannot be reproduced. Current AI systems are black boxes, creating liability issues for safety-critical applications. Meanwhile, companies are spending millions on generic LLM that are expensive and inconsistent for specialized science. Simply put: Today's AI-driven R&D cannot be trusted for real innovation.
Đang mở deck…
Trang 1
Khách hàng phù hợp nhất
- Regulated, science‑heavy enterprises needing trustworthy AI in safety‑critical workflows.
- Primary: biopharma R&D groups, hospitals/health systems, diagnostics manufacturers, and scientific CROs.
- Secondary: energy, advanced materials, manufacturing and supply‑chain operators seeking verifiable AI optimization.
Khách hàng tiêu biểu đang trả phí
- Available upon request (under NDA). Representative clinical users include 50+ hospitals across Asia for SmartDoseAI; additional academic/industry collaborators include Institut de Recherche pour le Développement, Hanoi University of Pharmacy, and Kyushu University.
- 6+ Q1 and A/A* conference papers - 5+ foundational AI/ML architecture patents filed; 3+ vertical patents (biosensors, biomarker discovery, supply chain) - LynxDetect moving through clinical translation - SupplyGuardAI demonstrated 70–90% early warning and 45–80% cost‑saving recoveries in past research projects - SmartDoseAI deployed in 50+ hospitals (Vietnam, Taiwan, Indonesia) - Member of NVIDIA Inception Program (since 2021); recipient of NVIDIA Academic Grant 2024